10-Q: Bespoke Extracts Reports Increased Sales but Continues to Face Going Concern Challenges in Q2 2024

Bespoke Extracts, Inc. saw a significant increase in sales during the second quarter of 2024, but continues to operate with a working capital deficit and negative cash flows, raising concerns about its ability to continue as a going concern.

Summary

• Bespoke Extracts, Inc. reported its financial results for the quarter ended June 30, 2024.
• The company experienced a notable increase in sales, reaching $278,163 for the quarter and $538,591 for the six-month period, primarily driven by pre-rolled joint sales.
• Despite the sales growth, the company's cost of goods sold also increased, impacting overall profitability.
• Operating expenses decreased compared to the same periods in 2023, mainly due to lower stock-based compensation expenses.
• The company reported a net loss of $260,895 for the quarter and $575,013 for the six-month period, which is an improvement compared to the losses in 2023.
• Bespoke Extracts had a working capital deficit of $1,439,890 and an accumulated deficit of $25,941,654 as of June 30, 2024.
• The company's financial statements have been prepared assuming it will continue as a going concern, but there is substantial doubt about its ability to do so due to negative cash flows and the working capital deficit.
• The company is dependent on generating profitable operations or obtaining financing to meet its obligations.

Sentiment

Score: 3

Explanation: The document highlights significant financial challenges, including a going concern warning, negative cash flows, and a substantial working capital deficit. While there is some sales growth, the overall financial health of the company is concerning, leading to a low sentiment score.

Positives

• The company experienced a significant increase in sales, indicating growing demand for its products.
• The net loss decreased compared to the same periods in the previous year, suggesting improved operational efficiency.
• Operating expenses decreased due to lower stock-based compensation expenses.
• The company secured additional financing through secured notes.

Negatives

• The company has a substantial working capital deficit, indicating potential liquidity issues.
• The company has negative cash flows from operations, raising concerns about its ability to sustain operations.
• The company has an accumulated deficit of over $25 million.
• The company's financial statements include a going concern warning, indicating significant uncertainty about its future viability.

Risks

• The company's ability to continue as a going concern is dependent on generating profitable operations or obtaining additional financing.
• There is no assurance that the company will be able to secure the necessary financing on acceptable terms.
• The company's reliance on a limited number of customers for a significant portion of its accounts receivable poses a risk.
• The company's debt obligations, including related party notes, could strain its financial resources.
• The company's internal controls are not effective due to material weaknesses, which could lead to errors in financial reporting.

Future Outlook

The company's future is uncertain, and its ability to continue as a going concern depends on generating profitable operations or securing additional financing. The company may need to curtail or cease operations if additional financing is not available.

Management Comments

• Management acknowledges the substantial doubt about the company's ability to continue as a going concern.
• Management states that the company is dependent on generating profitable operations or obtaining financing to meet its obligations.
• Management is taking measures to cure the identified weaknesses in internal controls.

Industry Context

The company operates in the regulated cannabis market, which is subject to evolving regulations and competition. The company's focus on pre-rolled joints indicates a specific market segment strategy. The company's financial challenges are not uncommon in the cannabis industry, where many companies struggle to achieve profitability.

Comparison to Industry Standards

• Bespoke Extracts' revenue growth is a positive sign, but its profitability and cash flow issues are concerning when compared to more established cannabis companies.
• Companies like Curaleaf and Green Thumb Industries, which are larger and more mature, have demonstrated stronger financial performance and access to capital.
• Smaller cannabis companies often face challenges in scaling operations and achieving profitability, which is reflected in Bespoke Extracts' current situation.
• The company's reliance on related party debt is not uncommon for early-stage cannabis companies, but it also indicates a higher risk profile compared to companies with access to traditional financing.

Related Party Transactions

• The company received additional advances from Infinity Management, LLC, an affiliate of the CEO, totaling $8,500 during the six months ended June 30, 2024.
• A note payable of $849,500 to Infinity Management, LLC is due June 30, 2025, and is intended to be repaid from a capital raise.
• Michael Feinsod, the CEO, is owed a total of $266,772 of accrued salary and accounts payable of $171,553.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern warning.
• Employees may be impacted by potential layoffs or operational changes if the company cannot secure additional financing.
• Customers may be affected by potential disruptions in product supply if the company faces financial difficulties.
• Creditors face the risk of non-payment if the company's financial situation does not improve.

Next Steps

• The company needs to secure additional financing to continue operations.
• The company needs to improve its profitability and cash flow.
• The company needs to address the material weaknesses in its internal controls.

Key Dates

Keywords

cannabis, marijuana, financial results, going concern, sales growth, net loss, working capital, secured notes, related party debt, stock options